[Editor’s Note: This post was co-authored by Becky Drees, Mark Minie, and Richard Gayle.] Several months back Spiral Genetics CEO Adina Mangubat lamented the difficulty of getting actionable information from now-abundant human DNA sequence data in an Xconomy post (“First Comes The $1,000 genome, Then Comes The $10,000 Analysis”. With the simultaneous publication of over … Continue reading “One Giant Leap for Human Genomics Science and Business”
Author: Becky Drees
Becky Drees is the chief scientist at Seattle-based Spiral Genetics. Dr. Drees is an accomplished molecular biologist. Becky’s professional background includes research on genome wide protein-protein interaction networks at the University of Washington, genetic interaction maps at the Institute for Systems Biology, and expression profiling of lymphocytes for HIV research at the Fred Hutchinson Cancer Research Institute. Her areas of scientific expertise include high-throughput screening, genome annotation, gene expression analysis, and next generation sequencing technologies. She holds a B.S. in Biochemistry from Texas A&M University and a Ph.D. in Molecular Biology from the University of California, Berkeley.